Align Technology, Inc. (NASDAQ:ALGN) Shares Sold by LPL Financial LLC

LPL Financial LLC decreased its holdings in Align Technology, Inc. (NASDAQ:ALGN – Get Rating) by 29.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 21,158 shares of the medical equipment provider’s stock after selling 8,978 shares during the quarter. LPL Financial LLC’s holdings in Align Technology were worth $4,462,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Intellectus Partners LLC grew its holdings in Align Technology by 2.5% in the 4th quarter. Intellectus Partners LLC now owns 1,214 shares of the medical equipment provider’s stock worth $256,000 after buying an additional 30 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in Align Technology by 0.7% in the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 5,790 shares of the medical equipment provider’s stock worth $1,221,000 after buying an additional 40 shares in the last quarter. Spire Wealth Management grew its holdings in Align Technology by 34.8% in the 4th quarter. Spire Wealth Management now owns 178 shares of the medical equipment provider’s stock worth $38,000 after buying an additional 46 shares in the last quarter. YHB Investment Advisors Inc. grew its holdings in Align Technology by 1.0% in the 4th quarter. YHB Investment Advisors Inc. now owns 4,845 shares of the medical equipment provider’s stock worth $1,022,000 after buying an additional 48 shares in the last quarter. Finally, Tsfg LLC boosted its stake in Align Technology by 40.0% during the 4th quarter. Tsfg LLC now owns 175 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 50 shares in the last quarter. Institutional investors and hedge funds own 84.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ALGN. Robert W. Baird increased their price target on Align Technology from $260.00 to $335.00 and gave the company an “outperform” rating in a research note on Thursday, February 2nd. Evercore ISI increased their price target on Align Technology from $230.00 to $375.00 and gave the company an “outperform” rating in a research note on Thursday, February 2nd. Morgan Stanley increased their price target on Align Technology from $314.00 to $383.00 and gave the company an “overweight” rating in a research note on Wednesday, April 19th. OTR Global raised Align Technology from a “mixed” rating to a “positive” rating in a research note on Friday, March 31st. Finally, Stifel Nicolaus increased their price target on Align Technology from $375.00 to $390.00 and gave the company a “buy” rating in a research note on Tuesday, April 18th. Two investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $347.78.

Align Technology Stock Performance

Shares of NASDAQ:ALGN opened at $292.30 on Wednesday. Align Technology, Inc. has a one year low of $172.05 and a one year high of $368.87. The stock has a fifty day moving average of $322.39 and a 200-day moving average of $269.60. The company has a market capitalization of $22.37 billion, a PE ratio of 72.17, a price-to-earnings-growth ratio of 2.70 and a beta of 1.60.

Align Technology Company Profile

(Get Rating)

Align Technology, Inc engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion.